Trial intelligence / Profile preview

Measles Vaccination in HIV-Infected and HIV-Uninfected Children

NCT00000815Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Live Attenuated Vaccines
Countries
2
01

Overview

A Phase 2 trial of measles virus vaccine live, M-M-R II in measles, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

measles virus vaccine liveM-M-R II
03

Conditions

measles

Beyond the preview

Go deeper on NCT00000815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000815.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call